Daiichi Sankyo Co., Ltd: PharmaVitae Profile Now Available at ReportsandReports
This analysis examines the historical and forecast performance for Daiichi Sankyo in the Rx pharmaceutical sector.
Eisai Co. Ltd: PharmaVitae Profile Now Available at ReportsandReports
This analysis examines the historical and forecast performance for Eisai in the prescription pharmaceutical sector.
Genzyme Corporation: PharmaVitae Profile Now Available at ReportsandReports
This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector.
Bristol-Myers Squibb Co.: PharmaVitae Profile Now Available at ReportsandReports
This analysis examines the historical and forecast performance for BMS in the prescription pharmaceutical sector.
Boehringer Ingelheim GmbH: PharmaVitae Profile Now Available at ReportsandReports
This analysis examines the historical and forecast performance for Boehringer Ingelheim in the Rx pharmaceutical sector.
Astellas Pharma Inc.: PharmaVitae Profile Now Available at ReportsandReports
This analysis examines the historical and forecast performance for Astellas in the Rx pharmaceutical sector.
Multiple Sclerosis Market Forecast Now Available at ReportsandReports
Sales of multiple sclerosis disease-modifying therapies exceeded $6.0 billion in 2008 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).
Italy Pharmaceutical Market Overview Generic Penetration Set to Rise Now Available at ReportsandReports
The prescription pharmaceutical market in Italy was valued at $24.9 billion in 2009.
Insurance Technology Spending Through 2014: Source Segmentation (Interactive Model) Now Available at ReportsandReports
This interactive model provides an unique full global view of technology spending in the insurance sector across both life and non-life business lines, with ability to view data at highly granular level.
Insurance Technology Spending Through 2014: Business Function Segmentation (Interactive Model) Now Available at ReportsandReports
This interactive model provides a unique consistent global view of insurance technology spend segmenting by business function area across life and non-life insurance sectors.